Skip To Main Content
Nisa Vorasoot on Muck Rack

Nisa Vorasoot

As seen in: Frontiers, Neurology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Nisa

Contact Nisa, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease

|
By Andrew J. McKeon, Connie Lesnick, Nisa Vorasoot
| Neurology Verified
Methods Standard Protocol Approvals, Registrations, and Patient Consents This retrospective study was approved by the Mayo Clinic Institutional Review Board (IRB, 21-001297). Medical records of patients who consented to research review were included.
Open in Who Shared Issue with article?

CDR2 and CDR2L line blot performance in PCA-1/anti-Yo paraneoplastic autoimmunity

|
By Khon Kaen, Nisa Vorasoot, Lidia Sabater
| Frontiers
Introduction Purkinje cytoplasmic autoantibody type 1 (PCA-1, also known as anti-Yo) is a biomarker of paraneoplastic neurological autoimmunity, usually manifesting as cerebellar ataxia (paraneoplastic cerebellar degeneration) in women with gynecologic or breast adenocarcinoma (1, 2).
Open in Who Shared Issue with article?
See all 2 articles